NMP22
NMP22 is a tumor marker for bladder cancer. NMP22 is the abbreviated form of Nuclear Matrix Protein Number 22.[1][2][3] It reflects the mitotic activity of cells.
References
- ^ Kumar A, Kumar R, Gupta NP (March 2006). "Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer". Jpn. J. Clin. Oncol. 36 (3): 172–5. doi:10.1093/jjco/hyi244. PMID 16520358.
- ^ Moonen PM, Kiemeney LA, Witjes JA (December 2005). "Urinary NMP22 BladderChek test in the diagnosis of superficial bladder cancer". Eur. Urol. 48 (6): 951–6, discussion 956. doi:10.1016/j.eururo.2005.09.002. PMID 16257108.
- ^ Bassi P, De Marco V, De Lisa A, et al. (2005). "Non-invasive diagnostic tests for bladder cancer: a review of the literature". Urol. Int. 75 (3): 193–200. doi:10.1159/000087792. PMID 16215303.
- v
- t
- e
Tumor markers
| Lymphoma |
|
|---|---|
| Lymphosarcoma |
|
| Thyroid cancer |
|
|---|---|
| Pheochromocytoma |
|
| Neuroendocrine tumors |
|
| Neuroblastoma |
| Brain tumor | |
|---|---|
| Astrocytoma | |
| NC/Melanoma |
respiratory
| Lung cancer | |
|---|---|
| Hemangiosarcoma (endothelium) |
| Colorectal cancer | |
|---|---|
| Pancreatic cancer | |
| Hepatocellular carcinoma |
urinary/
breast
| Ovarian tumor | |
|---|---|
| Testicular cancer | |
| Prostate cancer | |
| Germ cell tumor | |
| Bladder cancer |
|
| Breast cancer |
| Sarcoma | |
|---|---|
| Carcinoma (epithelium) |
| Rhabdomyosarcoma |
|---|
 | This biochemistry article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
